Submission Details
| 510(k) Number | K140591 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 07, 2014 |
| Decision Date | May 14, 2014 |
| Days to Decision | 68 days |
| Submission Type | Special |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K140591 is an FDA 510(k) clearance for the BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE - INJECTOR, a Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System (Class II — Special Controls, product code ONB), submitted by Becton, Dickinson & CO (Franklin Lakes, US). The FDA issued a Cleared decision on May 14, 2014, 68 days after receiving the submission on March 7, 2014. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K140591 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 07, 2014 |
| Decision Date | May 14, 2014 |
| Days to Decision | 68 days |
| Submission Type | Special |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | ONB — Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |
| Definition | Reconstitute And Transfer Antineoplastic And Other Hazardous Drugs In Healthcare Setting Indicated To Reduce Exposure Of Healthcare Personnel To Chemotherapy Agents In Healthcare Setting. |